Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Short-term Investments: 2019-2024

Historic Short-term Investments for KalVista Pharmaceuticals (KALV) over the last 3 years, with Apr 2024 value amounting to $178.6 million.

  • KalVista Pharmaceuticals' Short-term Investments was N/A to $86.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $86.0 million, marking a year-over-year change of. This contributed to the annual value of $178.6 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, KalVista Pharmaceuticals' Short-term Investments is $178.6 million, which was up 243.98% from $51.9 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Short-term Investments ranged from a high of $178.6 million in FY2024 and a low of $51.9 million during FY2020.
  • Moreover, its 1-year median value for Short-term Investments was $178.6 million (2024), whereas its average is $178.6 million.
  • Data for KalVista Pharmaceuticals' Short-term Investments shows a maximum YoY decreased of 24.53% (in 2020) over the last 5 years.
  • KalVista Pharmaceuticals' Short-term Investments (Yearly) stood at $51.9 million in 2020, then followed by $178.6 million in 2024.